ACB (Aurora Cannabis) Quality Rank


ACB Aurora Cannabis Inc ACB
59 GF Score
Price $2.86
GF Value $4.25
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is Aurora Cannabis Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Aurora Cannabis Quality Rank Related Terms

ACB
59GF Score
Aurora Cannabis Inc ACB
Quality Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Aurora Cannabis (ACB) Overvalued in 2026?

Based on GuruFocus' analysis, Aurora Cannabis stock appears to be undervalued. The current stock price of $2.86 is trading 32.7% below its estimated GF Value™ of $4.25. GuruFocus considers Aurora Cannabis to be Possible Value Trap.

Key valuation signals for ACB:

  • Quality Rank:
  • GF Value™: $4.25 vs. price of $2.86 (32.7% below fair value)
  • GF Score™: 59/100 with 2 warning signs

No single metric tells the full story. See the ACB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aurora Cannabis Business Description

Address 90B Street SW, Suite 2207, Edmonton, AB, CAN, T6X 1V8
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
59GF Score

Get the complete analysis for ACB

Quality Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.86
Price
$4.25
GF Value